Impact of left ventricular dysfunction on cytokines, hemodynamics, and outcome in bypass grafting

Annals of Thoracic Surgery

Volumn 62, Issue 1, 1996, Pages 184-190

  Deng, Mario C ^a,b   Dasch, Burkhard ^a   Erren, Michael ^a   Möllhoff, Thomas ^a   Scheld, Hans H ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^b UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; CYTOKINE; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 6; NORADRENALIN; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; EXTRACORPOREAL CIRCULATION; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; PRIORITY JOURNAL;

EID: 0030199677     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/0003-4975(96)00230-5     Document Type: Article

References (27)

1. 1. Westaby S. Organ dysfunction after cardiopulmonary bypass. A systemic inflammatory reaction induced by the extracorporeal circuit. Intensive Care Med 1987;13:89-95.
2. 2. Kirklin JK, Westaby S, Blackstone EH, Kirklin JW, Chenoweth DE, Pacifico AD. Complement and the damaging effects of cardiopulmonary bypass. J Thorac Cardiovasc Surg 1983;86:845-57.
3. 3. Wachtfogel YT, Harpel PC Edmunds LH Jr, Colman RW. Formation of C1s-C1-inhibitor, kallikrein-C1-inhibitor and plasmin alpha2-plasmin-inhibitor complexes during cardiopulmonary bypass. Blood 1989;73:468-71.
4. 4. Greeley WJ, Bushman GA, Kong DL, Oldham HN, Peterson MB. Effects of cardiopulmonary bypass on eicosanoid metabolism during pediatric cardiovascular surgery. J Thorac Cardiovasc Surg 1988;95:842-9.
5. 5. Colman RW. Platelet and neutrophil activation in cardiopulmonary bypass. Ann Thorac Surg 1990;49:32-4.
6. 6. Moat NE, Rebuck N, Shore DF, Evans TW, Finn AHR. Humoral and cellular activation in a simulated extracorporeal circuit. Ann Thorac Surg 1993;56:1509-14.
7. 7. Haeffner-Cavaillon N, Roussellier N, Ponzio O, et al. Induction of interleukin-1 production in patients undergoing cardiopulmonary bypass. J Thorac Cardiovasc Surg 1989;98: 1100-6.
8. 8. Finn A, Naik S, Klein N, Levinsky RJ, Strobel S, Elliott M. Interleukin-8 release and neutrophil degranulation after pediatric cardiopulmonary bypass. J Thorac Cardiovasc Surg 1993;105:234-41.
9. 9. Markewitz A, Faist E, Lang S, Endres S, Fuchs D, Reichart B. Successful restoration of cell-mediated immune response after cardiopulmonary bypass by immunomodulation. J Thorac Cardiovasc Surg 1993:105:15-24.
10. 10. Elgebaly SA, Hashmi FH, Houser SL, Alam ME, Doyle K. Cardiac-derived neutrophil chemotactic factors: detection in coronary sinus effluents of patients undergoing myocardial revascularization. J Thorac Cardiovasc Surg 1992;103:952-9.
11. 11. Steinberg JB, Kapelanski DP, Olson JD, Weiler JM. Cytokine and complement levels in patients undergoing cardiopulmonary bypass. J Thorac Cardiovasc Surg 1993;106:1008-16.
12. 12. Menasché P, Haydur S, Peynet J, et al. A potential mechanism of vasodilation after heart surgery. The temperature-dependent release of cytokines. J Thorac Cardiovasc Surg 1994;107:293-9.
13. 13. Hisatomi K, Isomura T, Kawara T. Changes in lymphocyte subsets, mitogen responsiveness, and interleukin-2-production after cardiac operations. J Thorac Cardiovasc Surg 1989;98:580-91.
14. 14. Deng MC, Wiedner M, Erren M, Möllhoff T, Assmann G, Scheid HH. Arterial and venous cytokine response to cardiopulmonary bypass for low risk CABG and relation to hemodynamics. Eur J Cardiothorac Surg 1995;9:22-9.
15. 15. Millar AB, Armstrong L, van der Linden J, et al. Cytokine production and hemofiltration in children undergoing cardiopulmonary bypass. Ann Thorac Surg 1993;56:1499-502.
16. 16. Butler J, Pillai R, Rocker GM, Westaby S, Parker D, Shale DJ. Effect of cardiopulmonary bypass on systemic release of neutrophil elastase and tumor necrosis factor. J Thorac Cardiovasc Surg 1993;105:25-30.
17. 17. Finkel MS, Oddis CV, Jacob TD, Watkins SC, Hattler BG, Simmons RL. Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science (Wash.) 1992;257: 387-9.
18. 18. Gulick T, Chung MK, Pieper SJ, Lange LG, Schreiner GF. Interleukin-1 and tumor necrosis factor inhibit cardiac myocyte β-adrenergic responsiveness. Proc Nati Acad Sci USA 1989;86:6753-7.
19. 19. Parrillo JE. Pathogenetic mechanisms in septic shock. N Engl J Med 1993;328:1471-7.
20. 20. Levine B, Kalman J, Mayer L, Fillit HM, Packer M. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med 1990;323:236-41.
21. 21. Deng MC, Kämmerling L, Erren M, et al. Relation of interleukin(IL)-6, tumor necrosis factor-α, IL-2, and IL-2-receptor-levels to cellular rejection, allograft dysfunction and mortality early after cardiac transplantation. Transplantation 1995;60:1118-24.
22. 22. Nora R, Abrams JS, Tait NS, Hiponia DJ, Silverman HJ. Myocardiac toxic effects during recombinant interleukin-2 therapy. J Natl Cancer Inst 1989;81:59-63.
23. 23. Deyton L, Walker R, Kovacs J, et al. Reversible cardiac dysfunction associated with interferon-alfa therapy in AIDS patients with Kaposi's sarcoma. N Engl J Med 1989;321: 1246-9.
24. 24. Hennein HA, Ebba H, Rodriguez JL, et al. Relationship of the proinflammatory cytokines to myocardial ischemia and dysfunction after uncomplicated coronary revascularization. J. Thorac Cardiovasc Surg 1994;108:626-35.
25. 25. Chrousos GP. The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. N Engl J Med 1995;332: 1351-62.
26. 26. Hocking DC, Phillips PG, Ferro TJ, Johnson A. Mechanisms of pulmonary edema induced by tumor necrosis factor-α. Circ Res 1990;67:68-77.
27. 27. Maury CPJ, Teppo AM. Circulating tumour necrosis factor-α (cachectin) in myocardial infarction. J Intern Med 1989;225: 333-6.